Arca Biopharma Stock Stock News Today

ABIO -  USA Stock  

USD 2.31  0.04  1.70%

Arca Biopharma Stock News module provides quick insight into current market opportunities from investing in Arca Biopharma. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Arca Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to Arca Biopharma Hype Analysis, Arca Biopharma Correlation and Arca Biopharma Performance.
  
Refresh
Arca Biopharma stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arca Biopharma daily returns and investor perception about the current pice of Arca Biopharma as well as its diversification or hedging effects on your existing portfolios.
six days ago at www.macroaxis.com         
Arca Biopharma exotic insider transaction detected
Macroaxis News
over a week ago at www.macroaxis.com         
Arca Biopharma exotic insider transaction detected
Macroaxis News
over two weeks ago at www.nasdaq.com         
TCMD Expects 13-15 percent Revenue Growth In 2022, AXSM On Watch, QURE Awaits Huntingtons Trial Data...
nasdaq News
over two weeks ago at www.macroaxis.com         
Arca Biopharma exotic insider transaction detected
Macroaxis News
over two weeks ago at www.macroaxis.com         
Sale by Funicular Fund Lp of 7500 shares of Arca Biopharma
Macroaxis News
over three weeks ago at www.macroaxis.com         
Sale by Funicular Fund Lp of 7000 shares of Arca Biopharma
Macroaxis News
over three weeks ago at www.marketscreener.com         
ARCA biopharma Establishes Special Committee of the Board of Directors - Form 8-K - Marketscreener.c...
news
over a month ago at politicalbeef.co.uk         
Atrial Fibrillation Drugs Market Share And Forecast Boehringer Ingelheim, Janssen Pharmaceuticals, S...
news
over a month ago at www.macroaxis.com         
Purchase by Funicular Fund Lp of 17410 shares of Arca Biopharma
Macroaxis News
over a month ago at www.macroaxis.com         
Purchase by Funicular Fund Lp of 69398 shares of Arca Biopharma
Macroaxis News
over a month ago at www.macroaxis.com         
Purchase by Funicular Fund Lp of 27450 shares of Arca Biopharma
Macroaxis News
over a month ago at www.fortbendnow.com         
Atrial Fibrillation Drugs Market Size, Growth And Forecast ARCA Biopharma, Baxter International Inc....
news
over a month ago at www.macroaxis.com         
Purchase by Funicular Fund Lp of 122342 shares of Arca Biopharma
Macroaxis News
over a month ago at www.investorsobserver.com         
Correction Sector Update Health Care Stocks Finishing Near Friday Session Highs - InvestorsObserver
Investors Business Daily at Macroaxis
over a month ago at www.investorsobserver.com         
Sector Update Health Care Stocks Edging Higher in Friday Trading - InvestorsObserver
Investors Business Daily at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Arca Biopharma that is available to investors today. That information is available publicly through Arca Biopharma media outlets and privately through word of mouth or via Arca Biopharma internal channels. However, regardless of the origin, that massive amount of Arca Biopharma data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arca Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arca Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arca Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arca Biopharma alpha.

Arca Biopharma Performance against DOW

 Price Growth (%)  
      Timeline 
1
EPS Reported03/14/2022
2
Unclassified Event03/28/2022
3
EPS Estimate03/31/2022
4
Purchase by Funicular Fund Lp of 122342 shares of Arca Bioph...04/04/2022
5
Purchase by Funicular Fund Lp of 27450 shares of Arca Biopha...04/07/2022
6
Purchase by Funicular Fund Lp of 69398 shares of Arca Biopha...04/12/2022
7
Purchase by Funicular Fund Lp of 17410 shares of Arca Biopha...04/14/2022
8
ARCA biopharma Establishes Special Committee of the Board of...04/18/2022
9
Sale by Funicular Fund Lp of 7000 shares of Arca Biopharma04/20/2022
10
Sale by Funicular Fund Lp of 7500 shares of Arca Biopharma04/27/2022
11
EPS Reported05/02/2022
12
Financial Statements05/05/2022
13
Arca Biopharma exotic insider transaction detected05/09/2022
14
Arca Biopharma exotic insider transaction detected05/11/2022
Please continue to Arca Biopharma Hype Analysis, Arca Biopharma Correlation and Arca Biopharma Performance. Note that the Arca Biopharma information on this page should be used as a complementary analysis to other Arca Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Arca Biopharma Stock analysis

When running Arca Biopharma price analysis, check to measure Arca Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arca Biopharma is operating at the current time. Most of Arca Biopharma's value examination focuses on studying past and present price action to predict the probability of Arca Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arca Biopharma's price. Additionally, you may evaluate how the addition of Arca Biopharma to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Arca Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arca Biopharma. If investors know Arca Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arca Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arca Biopharma is measured differently than its book value, which is the value of Arca Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of Arca Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arca Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arca Biopharma's market value can be influenced by many factors that don't directly affect Arca Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arca Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arca Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arca Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.